Drug Profile
Research programme: antifungals - Ceragenix
Alternative Names: CGX-813Latest Information Update: 07 May 2010
Price :
$50
*
At a glance
- Originator Ceragenix Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 07 May 2010 Discontinued for Mycoses in USA (Topical)
- 22 May 2008 Early research in Mycoses in USA (Topical)